Factors Influencing Illicit Drug Substance Abuse and Its Perceived Psychosocial Impact Among Individuals Undergoing Deaddiction Treatment at Male Drug Rehabilitation Centers of Eastern Nepal
Addiction and Health · 24.12.2025 · 17 · 1647
DOI: 10.34172/ahj.1647 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addiction and Health, online erschienen am 24.12.2025. Verfasst von Prasanna Dahal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Purbanchal University School of Health Sciences, Sundarharaicha, Gothgaun, Morang, Nepal. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Understanding drug abuse triggers is crucial for preventing youth from succumbing to addiction. This study aimed to identify the drivers and psychosocial factors influencing illicit drug-substance abuse among individuals undergoing deaddiction treatment at male drug rehabilitation centers in eastern Nepal.
Method
A cross-sectional study was conducted in 14 registered drug rehabilitation centers in Koshi Province, Nepal. The determinants and psychosocial impact were assessed using a semi-structured, five-point Likert scale questionnaire, and an overall factor mean score>2.5 was considered high. Bivariate and logistic regression analyses were used to examine the relationships between predictors and outcome variables.
Findings
Overall, 229 participants with a median age of 25 years (Q1=21, Q3=29) were surveyed; the majority had finished secondary-level education (42.4%). Diazepam (66.4%) and tramadol (48.5%) were the most frequently abused pharmaceutical products, whereas marijuana (92.1%) and brown sugar (62%) were the most commonly abused illicit substances. The most common sources of acquiring illicit products were peers (84.7%), cross-border trade (74.2%), and pharmacies (53.3%). Exploratory analysis revealed that the family, socioeconomic factors, peers, and school-related factors had a high influence on illicit drug or substance abuse, and these factors were significantly associated with higher odds of developing adverse psychosocial impact (P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Purbanchal University School of Health Sciences, Sundarharaicha, Gothgaun, Morang, Nepal.
- Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of Queensland, Brisbane, Australia.
- Department of Research and Academics, Kathmandu Cancer Center, Thathali, Bhaktapur, Nepal.
- NIHR Patient Safety Research Collaboration, Newcastle University, Newcastle Upon Tyne, United Kingdom.
- Department of Pharmacy, Faculty of Health, School of Clinical Sciences, Queensland University of Technology, Brisbane, Australia.
- Department of Clinical Pharmacology and Therapeutics, BP Koirala Institute of Health Sciences, Dharan, Nepal.
ORCID-Profile: Prasanna Dahal, Shakti Shrestha, Sunil Shrestha, Rajeev Shrestha, Bhuvan Kc, Kadir Alam
Zitieren
APA
Dahal, P., Shrestha, S., Shrestha, S., Shrestha, R., Kc, B., & Alam, K. (2025). Factors Influencing Illicit Drug Substance Abuse and Its Perceived Psychosocial Impact Among Individuals Undergoing Deaddiction Treatment at Male Drug Rehabilitation Centers of Eastern Nepal. Addiction and Health, 17, 1647. https://doi.org/10.34172/ahj.1647
Vancouver
Dahal P, Shrestha S, Shrestha S, Shrestha R, Kc B, Alam K. Factors Influencing Illicit Drug Substance Abuse and Its Perceived Psychosocial Impact Among Individuals Undergoing Deaddiction Treatment at Male Drug Rehabilitation Centers of Eastern Nepal. Addiction and Health. 2025;17:1647. doi:10.34172/ahj.1647
BibTeX
@article{Dahal2025,
author = {Dahal, Prasanna and Shrestha, Shakti and Shrestha, Sunil and Shrestha, Rajeev and Kc, Bhuvan and Alam, Kadir},
title = {Factors Influencing Illicit Drug Substance Abuse and Its Perceived Psychosocial Impact Among Individuals Undergoing Deaddiction Treatment at Male Drug Rehabilitation Centers of Eastern Nepal},
journal = {Addiction and Health},
year = {2025},
volume = {17},
pages = {1647},
doi = {10.34172/ahj.1647}
}
EUVIMED